A1.84 Switching off B cells by Fc-engineered anti-CD19 antibody (XmAb5871)

Daniel Szili; Marcell Cserhalmi; Zsuzsanna Bankó; Gyorgy Nagy; David E Szymkowski; Gabriella Sármay

doi:10.1136/annrheumdis-2013-205124.83

Article info

1. Rheumatoid arthritis

A1.84 Switching off B cells by Fc-engineered anti-CD19 antibody (XmAb5871)

Authors

Daniel Szili 1Department of Immunology, Eötvös Loránd University, Budapest, Hungary; PubMed articles Google scholar articles
Marcell Cserhalmi 1Department of Immunology, Eötvös Loránd University, Budapest, Hungary; PubMed articles Google scholar articles
Zsuzsanna Bankó 1Department of Immunology, Eötvös Loránd University, Budapest, Hungary; PubMed articles Google scholar articles
Gyorgy Nagy 2Department of Rheumatology, Buda Hospital of Hospitaller Brothers of St. John, Budapest, Hungary PubMed articles Google scholar articles
David E Szymkowski 3Xencor Inc., Monrovia, CA USA PubMed articles Google scholar articles
Gabriella Sármay 1Department of Immunology, Eötvös Loránd University, Budapest, Hungary; PubMed articles Google scholar articles

Citation

Szili D, Cserhalmi M, Bankó Z, et al

A1.84 Switching off B cells by Fc-engineered anti-CD19 antibody (XmAb5871)

Annals of the Rheumatic Diseases 2014;73:A37.

Publication history

First published January 31, 2014.

Online issue publication

October 25, 2017

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Main menu

Authors

Citation

Publication history

Request permissions

Copyright information

Log in using your username and password

Main menu

Log in using your username and password

You are here

Authors

Citation

Publication history

Request permissions

Copyright information

Read the full text or download the PDF:

Log in using your username and password